7-Bromo-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine, 95%, 5g

3-BROMO-N-METHOXY-N-METHYLPICOLINAMIDE, 95.0%, 5g

2-(Piperazin-1-yl)acetic acid ethyl ester, 98.0%, 10g

1,2-Dipalmitoyl-sn-glycerol, ��98.0%, 1g

4-Acetyl-2-cyanopyridine, 98%, 5g

2-(Pyridin-2-yl)-4,5-dihydrooxazole, 96.0%, 100mg

Recipientes de vidrio para muestras 100 lugares, azul 1 pieza

Báscula analítica y de precisión serie Entris® II Modelos con ajuste interno, no certificada, 0,01 g, 4200 g, BCE4202i-1S

4-[(butylamino)methyl]-2-ethoxyphenol hydrochloride, 95.0%, 1g

2-Chloro-5-pyrimidinecarbonitrile, 97.0%, 5g

N-(Azetidin-3-yl)-2,2,2-trifluoroacetamide hydrochloride, 97%, 10g

methyl 3-(4-bromo-1H-pyrazol-1-yl)propanoate, 95.0%, 1g

(S)-tert-Butyl 2,2-dimethyl-4-(2-oxoethyl)oxazolidine-3-carboxylate, 95.0%, 250mg